• CHIR-99021 (CT99021): Redefining Human iPSC Neuron Assays

  2026-05-11

  Explore how CHIR-99021 (CT99021) empowers advanced modeling of human sensory neurons from iPSCs, revealing new frontiers in Wnt/β-catenin pathway modulation and disease research. This article delivers in-depth, evidence-backed insights beyond pluripotency maintenance.

• Perospirone (SM-9018 Free Base): Optimizing Schizophrenia an

  2026-05-11

  Perospirone (SM-9018 free base) stands out with dual action on serotonergic/dopaminergic receptors and vascular Kv1.5 channels, enabling nuanced schizophrenia and cardiovascular research models. This guide translates cutting-edge mechanistic insights into actionable protocols and troubleshooting strategies for translational scientists.

• Acifran: Structural Insights Redefining Lipid Metabolism Res

  2026-05-10

  This thought-leadership article explores Acifran ((R)-5-methyl-4-oxo-5-phenyl-4,5-dihydrofuran-2-carboxylic acid) as a powerful, selective agonist for HM74A/GPR109A and GPR109B, contextualized by recent cryo-EM breakthroughs clarifying ligand-receptor interactions. Translational researchers are guided through mechanistic underpinnings, experimental best practices, and strategic implications for metabolic disorder research. By bridging structural biology, pharmacology, and workflow optimization, this piece advances the discourse beyond standard product pages—highlighting how Acifran, available from APExBIO, is catalyzing the next generation of lipid signaling investigations.

• Sulfo-NHS-Biotin: Mechanistic Precision in Translational TPD

  2026-05-09

  Explore how Sulfo-NHS-Biotin enables high-precision cell surface protein labeling for next-generation targeted protein degradation (TPD) strategies. This article integrates mechanistic insight, protocol optimization, and strategic guidance for translational researchers—bridging foundational chemistry with emerging extracellular vesicle-based TPD platforms. Evidence-backed discussion, competitive analysis, and a forward-looking outlook are provided to guide impactful experimental design.

• Targeting AR and ARv7 in TNBC: EPI-001’s Modulatory Effects

  2026-05-08

  This study elucidates the clinical significance of androgen receptor (AR) and its splice variant ARv7 in triple-negative breast cancer (TNBC), linking their expression to poor prognosis and metastasis. By investigating the effects of AR/ARv7 inhibition in TNBC cell lines, particularly with the N-terminal domain inhibitor EPI-001, the research highlights new mechanistic insights and therapeutic targets for AR-driven TNBC.

• Partial BACE1 Inhibition Reduces Amyloid Beta Without Synapt

  2026-05-08

  Satir et al. (2020) demonstrated that moderate inhibition of BACE1 can lower amyloid beta production by up to 50% in neuronal cultures without impairing synaptic transmission. These findings provide a mechanistic rationale for titrating BACE inhibitor exposure in Alzheimer's disease research to balance efficacy and neuronal safety.

• Pseudo-UTP: Optimizing RNA Stability for mRNA Vaccine Succes

  2026-05-07

  Explore how pseudo-modified uridine triphosphate (Pseudo-UTP) advances RNA stability and functionality in mRNA synthesis. This article reveals new experimental insights and practical protocol guidance that set it apart from existing resources.

• Self-Assembling Virus-Mimicking Particles for Targeted mRNA

  2026-05-07

  This article reviews the development of enveloped virus-mimicking particles (EVMPs) that enable efficient, extrahepatic delivery of therapeutic mRNA, such as Mouse Interleukin-12 mRNA, to organs beyond the liver. The study's modular, bottom-up design overcomes hepatic tropism and immunogenicity barriers, advancing the field of mRNA-based immunotherapy.

• Streptavidin-Cy3 (K1079): Precision Biotin Detection in Meta

  2026-05-06

  Explore how Streptavidin-Cy3 empowers quantitative and reproducible biotin detection in advanced metastasis research. This article delves into protocol parameters, critical insights from recent nasopharyngeal carcinoma studies, and distinct assay optimization strategies.

• DAPI Solution (1 mg/mL): Advanced Nuclear Visualization Prot

  2026-05-06

  DAPI Solution (1 mg/mL) enables robust nuclear visualization and apoptosis detection in fixed, dead, and permeabilized cells. This article translates cutting-edge PAD4 inhibitor research into actionable DAPI staining workflows, with troubleshooting insights and comparative analysis across microscopy and flow cytometry platforms.

• Applied Insights: Dibutyryl-cAMP, Sodium Salt in cAMP Pathwa

  2026-05-05

  Dibutyryl-cAMP, sodium salt stands out as a precise, cell-permeable tool for dissecting cAMP signaling in neuronal and inflammation studies. This guide spotlights experimental workflows, troubleshooting strategies, and advanced applications, helping researchers leverage DBcAMP sodium salt to drive discovery in protein kinase A activation and neuronal reprogramming.

• Y-27632: ROCK Inhibitor Workflows for Cytoskeletal and Cance

  2026-05-05

  Y-27632, a highly selective ROCK inhibitor from APExBIO, empowers researchers to dissect cytoskeletal organization and investigate cancer cell adaptation under ribotoxic stress. This article delivers actionable protocols, advanced use-cases, and troubleshooting guidance that uniquely position Y-27632 as a cornerstone tool for both cell biology and translational oncology.

• Novel PDK4 Inhibitors for Metabolic Diseases: Key Advances a

  2026-05-04

  This study reports the development of novel allosteric pyruvate dehydrogenase kinase 4 (PDK4) inhibitors, with compound 8c demonstrating strong in vitro potency and promising in vivo efficacy in metabolic and allergic disease models. The findings provide a new scaffold for targeted metabolic disease therapy and highlight translational opportunities.

• ISRIB (trans-isomer): Advanced PERK Inhibition for ER Stress

  2026-05-04

  ISRIB (trans-isomer) redefines ER stress research and fibrosis modeling by providing unmatched selectivity as a PERK inhibitor and robust reversal of eIF2α phosphorylation. Its unique mechanism enables precise modulation of ATF4-dependent pathways, facilitating apoptosis assays and cognitive enhancement with superior experimental control.

• Angiotensin II in Vascular Aging: From Mechanism to AAA Biom

  2026-05-03

  Explore how Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) drives vascular aging, cellular senescence, and the emergence of novel biomarkers for abdominal aortic aneurysm (AAA) diagnosis. This in-depth analysis uniquely links peptide signaling with translational assay design, offering new perspectives for vascular research.

556 records 19/38 page Previous Next First page 上5页 1617181920 下5页 Last page